NCT00189774View on ClinicalTrials.gov

Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Type 2 Diabetes MellitusDiabetes Mellitus, Type II
Interventions
DRUG

nateglinide

Trial Locations (7)

Unknown

Chubu Region

Chugoku Region

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Tohoku Region

Sponsors
All Listed Sponsors
collaborator

Ajinomoto USA, INC.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY